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Abstract 
 
Thujone is a natural compound found in plants such as “wormwood” and “sage” and 
it’s also found in the alcoholic drink “Absinthe”. Thujone has been suggested as a 
neurotoxic compound and reported to modulate GABAA receptors. In this study, we 
investigated the pharmacology of Thujone on nicotinic receptors expressed in Xenopus 
oocytes using the two electrode voltage clamp method. Thujone (100µM) caused an 
80% inhibition of Acetylcholine (ACh) induced currents in human α7-nAChRs 
expressed in frog oocytes while only 30% inhibition currents in α4β2 expressed 
oocytes and no effect on α3β4, α3β2 and α4β4 nAChRs. The mechanisms of Thujone 
effect on the α7-nAChR were further investigated and found to be independent of 
membrane potential and did not compete with ACh. Furthermore, Thujone did not 
affect the activity of endogenous Ca2+ dependent Cl- channels. In conclusion, Thujone 
inhibits human nAChRs with different potencies. 
Keywords: Thujone, Xenopus oocytes, nicotinic acetylcholine receptors.  
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 )cibarA ni( tcartsbA dna eltiT
 
 أثارالمركب  يةالنيكوتينالاسيتايل كولين مستقبلات  صفات ثوجون على
 
 ملخص
تم العثور على مركب طبيعي ثوجون في النباتات مثل " مرارة " و " حكيم " وانها وجدت أيضا في المشروبات 
 ABAGAمستقبلات  هذا بعمله علىو ع ا الأ يؤثر على قدثوجون  أن " . وقد اقترح ehtnisbAالكحولية " 
 المكونة من يةالنيكوتينالاسيتايل كولين  ثوجون على مستقبلات صفات التحقيق في ب نقوم نحن. في هذه الدراسة، 
) و ذالك باستخدام تقنية تثبيت الجهد الكهربائي في البويضة suponeXو المستنسخة في بويضات ضفادع ( 7ألفا 
 في حين أن هت الاصلية. التيار حجم من ٪ 08) تسبب في تثبيط  Mμ001ثوجون (  كهربائين.باستخدام قطبين 
ة مستنسخة بقنوات الاسيتيل كولين النيكوتيني على بويضاتمن حجم التيار الأصلي   ٪ 03 تثبيطبفقط  ثوجون قام
 4β4α،  2β3α،  4β3α بويضات مستنسخة بقنوات الاسيتيل كولين ليس له تأثير علىكما  2β4α المكونة من
جدت و 7المكونة من ألفا  يةالنيكوتينالاسيتايل كولين  على مستقبلات   في صفات ثوجون التحقيقمزيد و عند   .
ة غشاء المحتملة ، ولم يتنافس مع أدن تشافيز . وعلاوو أن التثبيت ليس له علاقة بالتيار الكهربائي لدى الخلية
. لذاتيةا قنوات الكلوريد المعتمدة على الكالسيوم و المتواجدة في غشاء البويضة  ؤثر علىي لمثوجون على ذلك ، 
 ية.النيكوتينالاسيتايل كولين  على مستقبلات وصفات ذاتية مختلفة فعالية  في الختام، ثوجون لديهو
 
 النيكوتينية .، مستقبلات الأستيل كولين )suponeX( فادعضل ثوجون ، البويضات مفاهيم البحث الرئيسية:
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Chapter 1: Introduction 
1.1 Artemisia absinthium L (Wormwood) 
 The Artemisia Absinthium shown in Figure 1.1, named after the Roman “goddess 
Artemis” also called “wormwood”, is a well-known herb used for medicine and 
culinary purposes over many centuries. It comes from the family called “Asteraceae” 
that has 22 different Artemisia species such as: Artemisia vulgaris, Artemisia 
arbotanum and Artemisia santonicum. It was also given the name “wormwood” due 
to its bitterness and strong taste and it has been included in the alcoholic beverage 
“Absinthe” which means undrinkable. (Belhattab, Amor, Barroso, Pedro, & 
Figueiredo, 2014; Tobyn, Denham, & Whitelegg, 2011) 
 
     Figure 1.1: Artemisia absinthium L (wormwood) (Tobyn et al, 2011) 
 Since the ancient Egyptian times (460-377 B.C.), wormwood extracts have been 
used in the treatment of menstrual pain and rheumatism (Lachenmeier, 2010). During 
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the 18th century alcoholic wormwood extracts were produced and in the beginning of 
the 19th century, the alcoholic distillates of Absinthe and similar drinks were produced 
on a larger scale in Europe. (Baydar, Sangun, Erbas, & Kara, 2013; Lachenmeier, 
2010). “Absinthe” also named “the green fairy, Green Muse and Green Goddess” 
became a very popular drink especially in France among many artists such as: Vincent 
van Gogh, Paul Verlaine, Pablo Picasso, Charles Baudlaire and Oscar Wilde. 
Absinthe is a highly alcoholic beverage (45-75%) and it mostly contains essential oil 
extracts from different herbs such as: wormwood (Artemisia absinthium), peppermint 
(Mentha piperita), fennel seed (Foeniculum vulgare) and angelica (Angelica 
archangelica) (Lachenmeier, 2010; Dawidowicz and Dybowski, 2012). 
1.2 The plant Sage Lamiaceae 
 The plant Sage of the family Lamiaceae also called “Labiateae” is made of about 
2500 different species with the essential oils as the major component. The Sage herb 
produces its highest content of Thujone during the late autumn season. The Sage can 
also be called the Salvia herb and include the following:  
1.2.1 Dalmatian Sage: Extracts of the dried leaves of this plant contains 
Salvia officinalis, which can be found all over Europe making it the most widely 
used sage, mainly due to its high content of Thujone reaching up to 65%, 1,8-
ceniole up to 22% and camphor up to 38% of the total oil content as in Figure 
1.2.  
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 Figure 1.2: Salvia officinalis L.  (Picture taken from Wikipedia on 21/12/2014) 
1.2.2 Spanish Sage: As its name implies it is produced in Spain from the 
shrubs of the plant named Salvia lavandulifolia vahl. This plant has a 
considerably low content of Thujone of 1.3%. However, it has very high contents 
of 1,8-ceniole and camphor of the total oil (56% and 37%, respectively). 
1.2.3 Greek Sage: Salvia fruticosa miller has the highest contents of 1,8-
ceniole of 66% of the total oil and much lower concentrations of Thujone and 
camphor.  
1.2.4 Cretan Sage: Salvia pomifera has a high Thujone content between 
58%-83% of the total oil content with minimum camphor and 1,8-ceniole 
quantities. It’s found mainly in Turkey and Greece (Badawy & Abdelgaleil, 
2014; Baydar et al., 2013; Kokkini, Karousou, & Hanlidou, 2003; Lachenmeier, 
2010; Tobyn et al., 2011).  
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1.3 Thuja C. species (Red cedar) 
 This plant comes from the family Cupressacaea and it is subdivided into two 
main species; First is Thuja occidentalis shown in Figure 1.3, also called the 
“Eastern Abrovitae” or the “Atlantic red cedar” while the second is the Thuja plicata 
donn which is called the “Western Abrovitae” or the “Pacific red cedar”. These two 
subdivisions contain high amounts of Thujone, 50-52 % of the total oil content for 
Thuja occidentalis and 54-63% of the total oil content in the Thuja plicata donn. 
(Bouajaj et al., 2013; Tsiri et al., 2009; Zhang, Schneidmiller, & Hoover, 2013) 
 
 
 Figure 1.3: Thuja occidentalis L. (picture taken from Wikipedia on 21/12/2014)  
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1.4 Monoterpene Ketones 
 Thujone is a monoterpene ketone found as one of the main constituent’s (almost 
90% of total oil) in the essential oils of different kinds of plants. The essential oils are 
the lipophilic extracts or mixtures that are produced after the plant has been processed 
by different methods such as distillation. The monoterpenes are composed of 10 
carbon atoms with at least one double bond derived from two isoprene subunits (2-
methyl-1, 3-butadiene) that has a molecular formula of (C5H8)n (n referring to the 
isoprene units).  An example of major essential oil families are: Asteraceae, Apiaceae, 
Lamiaceae, Pinaceae and Rutaceae.  Monoterpenes are grouped into regular which is 
more common, and irregular such as those found in the family Astraceae e.g. 
Chrysanthemic acid. The regular monoterpenes are subdivided into ketones, alcohols, 
aldehydes and ethers such as those in the Figure 1.4 below. (Akhgar, Rajaei, & 
Alizadeh-Saljoughi, 2013; Aldred, Buck, & Vall, 2009; Amri et al., 2013; Badawy & 
Abdelgaleil, 2014; Belhattab et al., 2014; Lachenmeier, 2010)  
 
Figure 1.4: Structures of monoterpene aldehydes and ketones in essential oils (taken 
from Hall et al., 2004) 
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1.5 Thujone 
 Thujone, as previously mentioned, is available in large amounts from different 
plants. Thujone is a lipophilic bicyclic monoterpene ketone usually present in nature 
in two stereoisomers α-Thujone also called (-)-3-Thujone (CAS No. 546-80-5) and β-
Thujone also named (+)-β-Thujone (CAS No. 471-15-8) as in Figure 1.5 (Oz, Lozon, 
Sultan, Yang, & Galadari; Suramya Waidyanatha et al., 2013) 
   
Figure 1.5: Two dia-stereoisomers of Thujone (taken from Waidyanatha et al, 2013)  
 Thujone has been reported to have a neurotoxic effect in various earlier studies 
(Hold, Sirisoma, Ikeda, Narahashi, & Casida, 2000; Pelkonen, Abass, & Wiesner, 
2013; Polatoglu, Karakoc, & Goren, 2013; S. Waidyanatha et al., 2013). It has been 
proposed that Thujone intake causes mental deterioration and “Absinthism” which is 
manifested by hallucinations, depression and psychotic symptoms. Although large 
quantities of Absinthe were required for Absinthism to occur, prolonged exposure to 
Thujone has been reported to lead to neurotoxic effects similar to those seen in 
Absinthism  (Czyzewska & Mozrzymas, 2013; Lachenmeier, Emmert, Kuballa, & 
Sartor, 2006; Lachenmeier & Uebelacker, 2010). 
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 The popularity of Absinthe declined when it was associated with several psychotic 
effects, seizures, hallucinations, or mental prostration; all of which were summarized 
under the term Absinthism. In particular, the monoterpene Thujone was considered 
the active ingredient of absinthe. As a consequence, Absinthe was banned in Belgium 
in 1905, and soon after by Switzerland (1908), USA (1912), Italy (1913), France 
(1915), and Germany (1923). After its decline in popularity, Absinthe experienced a 
resurrection in 1988, when the European Commission allowed the processing of 
Thujone-containing plants to maximal concentration of 35 mg/ml in alcoholic spirits 
(European Council, 1988). Consequently, in recent years, research on Thujone and 
Thujone containing products increased significantly (Höld, Sirisoma, & Casida, 2001; 
Padosch, Lachenmeier, & Kroner, 2006). For example, it was reported that Thujone 
can bind to GABAA receptors, inhibit its function and cause convulsions (Hold et al., 
2000).  
1.5.1 Clinical applications of Thujone herbs 
  Thujone containing herbal products have been demonstrated to show clinically 
beneficial effects in the treatment of the acute common cold and cough (Naser, 
Bodinet, Tegtmeier, & Lindequist, 2005). It has also been shown that Thujone have 
some antibacterial activity against bacteria such as:  E. coli, K pneumonia, S Aureus 
and P aeruginosa (Tsiri et al., 2009). 
 The European Medicines Agency (EMA) also mentioned some of the 
pharmacological actions of the herb Artemisia absinthium in promoting relief for 
gastric dyspepsia. It was also suggested that Thujone has antipyretic, anthelmintic and 
analgesic properties. (EMEA/HMPC/234444/2008) The EMA also reported that the 
use of the herb Salvia officinalis is indicated for the inhibition of perspiration or 
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sweating making the herb antihidrotic. It was also reported that sage extracts have 
memory enhancing and gland secretion enhancing effects 
(EMA/HMPC/330383/2008) 
  In an earlier study, Thujone, when administered by intra peritoneal injection to 
mice, caused increased plaque forming cells in spleen,  increased natural killer cell 
(NK) activity, increased total white blood cell (WBC) count, antibody dependent 
cellular cytotoxicity (ADCC) and enhanced cytotoxic T lymphocyte generation 
(Siveen & Kuttan, 2011). It was proposed that Thujone enhances the release of 
cytokines such as interleukin 2 (IL-2) and interferon gamma (IFN-γ).  This is 
confirmed by the reduction of Dalton’s Lymphoma Ascites (DLA) induced solid 
tumor formation through modulation of immune mechanisms (Lachenmeier & 
Uebelacker, 2010; Siveen & Kuttan, 2011). 
1.5.2 Thujone toxicity studies 
 Over the years many groups have tested the toxicity profile of Thujone using 
different techniques; although most of these techniques were not performed in 
humans, animal studies on mice or rats can be used to help understand our human 
bodies. In 2010, Lachenmeier et al reported that gavage application of a racemic 
mixture of α, β-Thujone to four groups of 20 different weanling rats at doses of 0, 
12.5, 15, 50 mg/kg/day for a period of 13 weeks resulted in convulsions at the higher 
dose groups. The NOEL (No Observed Effect Level) for males was 12.5 mg/kg/day 
and it was not determined for females since convulsions happened early on in the 
experiment with the middle dose adjustments. In other experiments four groups of 20 
rats received the Thujone by gavage for 6 days a week for a period of 14 weeks with 
doses of 0, 5, 10, 20 mg/kg. Results show that 6 male and 9 female rats convulsed 
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when given a high concentration of Thujone and 4 rats died due to convulsions. It was 
suggested that the NOEL was 5 mg/kg/day for the females and 10 mg/kg/day for the 
males (Dawidowicz & Dybowski, 2012; Lachenmeier & Uebelacker, 2010). In 
another study, the reported NOEL was 10 mg/kg in males and 5 mg/kg in females 
(Pelkonen et al., 2013). 
 In an earlier study, Rice and Wilson (1976), identified the subcutaneous LD50 
(lethal dose in 50 percent of the population) of α-Thujone on mice to be 134 mg/kg 
while β-Thujone to be 442 mg/kg. Another single dose toxicity study by Pinto-
Sconamiglio (1967) suggested that the intra peritoneal dose of Thujone of 180 mg/kg 
body weight in rats would lead to lethal effects and convulsions. (Pelkonen et al., 
2013) However, another study reported that the intra peritoneal LD50 in mice was 45 
mg/kg body weight (Hold et al., 2000).  
 The results of United States NTP (National Toxicology Program) in 2011 indicated 
that gavage doses of both α-Thujone and a mixture of α, β-Thujone resulted in 
neurotoxicity (represented by showing signs of hyperactivity, tonic-clonic seizures 
and tremors) and increased mortality rates on B6C3F1 mice and Fischer 344 rats. The 
doses that were given were 0, 1, 3, 10, 30, or 100 mg/kg/day for a period of 14 days. 
The study also performed a 3 month toxicity experiment by giving the animals both 
α-Thujone and a mixture of α, β-Thujone in doses of 0, 6.25, 12.5, 25, 50 or 100 
mg/kg/day for 13 weeks by gavage. The higher dose groups showed a higher seizure 
rate along with high mortality rates when compared to the control and lower dose 
groups (Suramya Waidyanatha et al., 2013) (Lachenmeier & Uebelacker, 2010; 
Pelkonen et al., 2013). 
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 Chronic toxicity studies were also performed by the NTP by administering low 
doses of a racemic mixture of Thujone by gavage for a period of 2 years. The doses 
that were given were 0, 3, 6, 12 and 25 mg/kg per day for the B6C3F1 mice and doses 
of 0, 12.5, 25 and 50 mg/kg per day for the Fischer 344 rats. Results show increase 
mortality and seizures in both groups at the higher doses. They also show increased 
non-neoplastic lesions in the spleen and brains of Fischer 344 rats. Lesions were also 
present in the kidneys of male rats and in the female’s pituitary glands at the higher 
dose groups. The seizure and mortality NOEL for the rats was 12.5 mg/kg per day 
and 12 mg/kg per day for the mice (Pelkonen et al., 2013; Suramya Waidyanatha et 
al., 2013). 
 These studies also revealed the carcinogenicity potential for Thujone since there 
was significant increase in the female’s B6C3F1 mice micro nucleated erythrocytes 
when they were given the racemic mixture for a period of 3 months. It is also worth 
mentioning that Fischer F344 rats had an increase in the formation of benign 
pheochromocytoma of the adrenal medulla as well as perpetual gland neoplasms in 
the males when given high doses (Ashoor et al., 2011; Davis & de Fiebre, 2006; 
Pelkonen et al., 2013; Suramya Waidyanatha et al., 2013; Wu, Gao, & Taylor, 2014). 
1.5.3 Molecular and Cellular mechanisms of Thujone 
 As mentioned earlier, Thujone was found to cause neurotoxicity (represented by 
showing signs of hyperactivity, tonic-clonic seizures and tremors) and there have been 
several in-vivo and in-vitro investigations to clarify the mechanisms underlying the 
neurotoxic effects of Thujone.   
 
 
11 
 
1.5.3.1 The effect of Thujone on Ligand Gated Ion Channels 
 The ligand-gated ion channels allow the passage of ions by means of extracellular 
binding of ligands or neurotransmitters like Acetylcholine (ACh). In (Figure 1.6), 
Ligand-gated ion channels have been divided into five major families: 1) Cys-loop 
superfamily, 2) Glutamate (Glu)-gated family, 3) Adenosine Triphosphate ATP 
(Purinergic)-gated family, 4) Transient receptor family (TRP) family and 5) Acid-
sensitive ion channel (ASIC) family. The Cys-loop superfamily has also been 
subdivided into many receptor subtypes including: A) Nicotinic Acetylcholine 
Receptors, B) Serotonin type 3 Receptors, C) GABAA and GABAC Receptors, D) 
Glycine Receptors and E) Zinc-Gated Ion channels. (Briggs & Gopalakrishnan, 2007; 
Imoto, 2004; McGivern & Worley Iii, 2007; Millar & Gotti, 2009; Suppiramaniam, 
Abdel-Rahman, Buabeid, & Parameshwaran, 2010). 
  
 Figure 1.6: Ligand gated ion channels (picture taken from Nature Reviews) 
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 The Cys-loop superfamily is composed of a large N-terminal domain where the 
agonist will bind at one end and the C-terminus at the other making this adjacent 
cysteine pair important for channel gating, four transmembrane α-helices segments 
(M1-M4) and a variable intracellular loop between M3 and M4 shown in Figure 1.6. 
Some of these channels are excitatory receptors such as nicotinic acetylcholine and 
serotonin type 3 (5-HT3) receptors. They permeate mainly cations such as Ca
2+ and 
Na+ causing depolarization of the membrane. While others are named inhibitory such 
as GABAA and glycine receptors, and they selectively permeate anions such as Cl
- 
causing hyperpolarization or inhibition of neuronal firing s (Briggs & Gopalakrishnan, 
2007; Hold et al., 2000). 
 In an early study conducted to understand the mechanisms of Thujone action 
it was found that this compound acts on dorsal root ganglia of mice by inhibiting 
GABAA receptors that are mainly distributed in the central nervous system (CNS) 
(Hold et al., 2000). This effect was also seen in the (Hall et al., 2004) experiments 
involving Xenopus oocytes injected with α1β2γ2 GABAA receptors. The results of the 
study show that Thujone dia-stereoisomers have an inhibitory effect on these 
receptors. In another study done recently in cultured hippocampal neurons, α-
Thujone (100 µM) was able to inhibit miniature inhibitory postsynaptic currents 
(mIPSC) in patch clamp experiments (Szczot, Czyzewska, Appendino, & 
Mozrzymas, 2012); suggesting that Thujone effects the function of GABAA receptors 
by down regulating phasic or synaptic  GABAA transmission. However, subsequent 
studies showed that (Czyzewska & Mozrzymas, 2013) α-Thujone has an inhibitory 
effect on the phasic as well as the tonic or extra-synaptic GABAA transmission by its 
actions on different subunits of GABAA receptors. It was found that Thujone acted 
on α1β2δ receptors with highest potency, suggesting that tonic currents might be 
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more sensitive to Thujone than phasic currents (Czyzewska & Mozrzymas, 2013; 
Szczot et al., 2012). In another study on GABAA receptors in neonatal chicks, α-
Thujone was able to induce “anxiogenic-like” effects on behavior when administered 
centrally; the authors proposed that Thujone reduced the postsynaptic membrane 
receptors and caused suppression in stress induced increase of GABAA receptor 
recruitment   (Höld et al., 2001; Lachenmeier & Uebelacker, 2010; Rivera, Cid, 
Zunino, Baiardi, & Salvatierra, 2014).  
 The effects of Thujone are not limited to GABAA receptors. In patch clamp studies, 
Thujone was able to reduce serotonin type 3 receptor (5-HT3) activity by enhancing 
the binding of the ligand serotonin and strengthening the channel blocking potency. It 
was reported that, Thujone was involved in receptor desensitization in cultured human 
embryonic kidney (HEK 293) cells (Deiml et al., 2004; Qiao, Sun, Clare, Werkman, 
& Wadman, 2014). 
 Both, 5-HT3 and GABAA receptors are members of the LGIC family. However, 
nicotinic receptors are the prototype for LGIC, and the effects of Thujone on these 
receptors are currently unknown.  
1.5.3.2 The effect of Thujone on G-Protein Coupled receptors  
 G-protein coupled receptors also named “7TM receptors” are the largest group of 
receptors that have been identified to date with 800 different types. They are the most 
common site for drugs and chemicals. They are made of a single polypeptide that has 
an intracellular C-terminal domain and an extracellular N-terminal domain between 
these two domains consisting of seven hydrophobic trans-membranes (TM1-TM7) 
(Figure 1.7). These trans-membrane domains are also linked by intracellular and 
extracellular loops. Most GPCRs involve second messenger systems such as GS 
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(Stimulatory) and GI (Inhibitory) such as those involved in the binding of α-GTP 
which activates or inhibits adenylyl cyclase (AC) which ultimately modulates the 
synthesis of the second messenger cyclic adenosine monophosphate (cAMP) and 
eventually leads to a biological response (S. P. Alexander et al., 2013; Clark, 2012; 
Gotti et al., 1988; Oz, 2006)  
 
 Figure 1.7: GPCR Signal transduction (picture taken from Clark, 2012) 
 Cannabinoid receptors are a member of the GPCR class of receptors. Since 
“Absinthsm” has several symptoms (such as cognitive deficits) common with cannabis 
toxication, it was initially thought that Thujone modulates cannabinoid receptors. 
However, Thujone has failed to evoke responses in Cannabinoid receptors although it 
has a low binding affinity for these receptors since it was able to displace the binding 
of the agonist [3H]CP55940 with a Ki of 130 µM and Ki of 115 µM at the Cannabinoid 
receptor CB1 from rats P2 isolated membranes and CB2 in human isolated tonsil 
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membranes expressing the cannabinoid receptors, respectively (Meschler and Howlett, 
1999; Gotti and Clementi, 2004). Thus it has been concluded that Thujone does not 
evoke cannabinoid receptor responses. (Gotti & Clementi, 2004; Gotti, Fornasari, & 
Clementi, 1997; Gotti et al., 1988; Mahgoub et al., 2013; Meschler & Howlett, 1999; 
Oz, 2006; Oz, Al Kury, Keun-Hang, Mahgoub, & Galadari, 2014) 
1.6  Cholinergic system 
 The nervous system is a widely studied complex network with many different 
structures; it is divided into the central nervous system (CNS) which consists of the 
brain and spinal cord and the peripheral nervous system (PNS) which consists of the 
neurons outside the brain and spinal cord either named: “afferent” that bring or carry 
the signal towards the CNS from the periphery or “efferent” that carry the signal 
away from the CNS to the periphery. The “efferent” is also subdivided into 
“Somatic” which includes the voluntary neurons involved in motor control; and 
“Autonomic” which are involved in the involuntary neurons that control 
requirements of the vital functions of the body and everyday unconscious activities 
such as breathing and digestion (Clark, 2012; Clarke, 2008a; Cuello, 2009).  
 Over the past century scientists were able to map most of these systems and the 
main neurotransmitters involved in the mechanisms of actions of these systems. Our 
focus in this study is the cholinergic system with acetylcholine (ACh) being the most 
abundant neurotransmitter involved in the central and peripheral nervous systems. It 
is synthesized in the synaptic axon and the neuronal cytoplasm by choline 
acetyltranferase enzyme which requires the presence of both acetyl coenzyme A and 
choline as substrates. Once formed ACh is stored in synaptic vesicles in the axon. 
Membrane depolarization will cause an increase in the intracellular Ca2+ and the 
release of the neurotransmitter ACh from the vesicles into the synaptic cleft by 
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exocytosis (Figure 1.8). Once released ACh can either bind to receptors on pre or 
post-synaptic membranes or get hydrolyzed by the enzyme Acetylcholineesterase 
(AChE) into Acetate and Choline which will be taken up by the axon (Clementi, 
Fornasari, & Gotti, 2000; Cooper, Bloom, & Roth, 2003; Hendrickson, Guildford, 
& Tapper, 2013; Mufson, Counts, & Ginsberg, 2009; Westfall, 2009). 
 
 Figure 1.8: Summary of synthesis and release of Acetylcholine from cholinergic 
neuron. AcCoA: Acetyl coenzyme A. (picture taken from (Clark, 2012; Clarke, 
2008b). 
 The brain contains several ACh innervations called cholinergic pathways.  It has 
been shown that ACh is the neurotransmitter at all autonomic ganglionic neurons, 
neuromuscular junctions and parasympathetic post-ganglionic synapses (Cooper et 
al., 2003; Gotti et al., 2007). In the central nervous system (CNS) the 
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neurotransmitter ACh plays a role in several physiological functions such as 
learning, attention, motor control and memory through multiple and complex 
cholinergic pathways. These cholinergic pathways have been recently mapped 
through various immuno-histochemical staining techniques and it has been shown 
that these pathways originate from the basal forebrain. Scientists then introduced the 
Ch1-Ch4 nomenclature of these cholinergic neurons. Ch1 represents the cholinergic 
neurons of the medial septum, Ch2 consist of the diagonal band of Broca also 
referred as the “Vertical limb”. Ch3 neurons compromises the “horizontal limb” and 
finally, Ch4 nomenclature contains the largest group of cholinergic neurons almost 
90% which are in the cells of the nucleus basalis (NB) (Figure 1.9). The nucleus 
basalis projects to the cerebral cortex but the cortex doesn’t contain cholinergic 
neurons, it receives projections from the limbic, amygdala and paralimbic 
projections; thus the term “nucleus basalis” can be referred to the cholinergic and 
non-cholinergic components, however, only Ch4 is used in cholinergic innervations. 
The second group of cholinergic pathways can be described by their presence in the 
upper brain stem projecting from the rostral midbrain to the midpontine level. This 
group can also be subdivided into Ch5 mainly in the pedunculopontine nuclei, Ch6 
in the lateral dorsal tegmental nucleus connecting to the thalamus. Ch7 neurons 
innervate the interpeduncular nucleus in the medial habenula of the epithalamus. 
Finally, Ch8 neurons are in the mesopontine region inside the parabigeminal nucleus 
innervating the superior colliculus. (Figure 1.9) summarizes these cholinergic 
pathways.  (Cooper et al., 2003; Cuello, 2009; Gotti & Clementi, 2004; Gotti et al., 
1997; Keverne & Ray, 2005; Mesulam, 2009; Mufson et al., 2009; Oz, Lorke, & 
Petroianu, 2009)   
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 Figure 1.9: Summary of the Ch1-Ch8 neurons. Amg:amygdala, CC: corpus 
callosum, Fx: fornix, Hippo: hippocampus, Ext cap: external capsule, IC: internal 
capsule, Th: thalamus, SC: superior colliculus, intped nucleus: interpeduncular 
nucleus (Taken from: (Mufson et al., 2009). 
1.7 Cholinergic receptors “Cholinoceptors” 
 After acetylcholine has been released into the synaptic cleft, it binds to the 
cholinergic receptors either on the pre-synaptic or on the post-synaptic nerve 
terminal. There are two different types of “Cholinoceptors”; the muscarinic 
“mAChR” and nicotinic receptors “nAChR” with different affinities and efficacies 
for ACh. The muscarinic receptors are G-protein coupled receptors and they have 
the highest affinity for the alkaloid found in mushrooms called: “Muscarine” and 
lower affinities for nicotine. The nicotinic receptors on the other hand have a higher 
affinity for nicotine and they are ligand gated ion channels (Clark, 2012; Cuello, 
2009; Eaton, Ospina, Rodrı́guez, & Eterović, 2004; Keverne & Ray, 2005; Mesulam, 
2009). 
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1.7.1 Muscarinic receptors 
 As it was mentioned previously, these receptors are G-protein coupled 
receptors and their signal transduction mechanism involves the activation of G-
proteins. There are five subtypes of the muscarinic receptors M1-M5 as have been 
described by binding studies, gene cloning and pharmacological methods. These 
metabotropic receptors are located in almost all organs and tissues which are 
innervated by parasympathetic nerves. The M1 is located mainly in the gastric 
parietal cells, whereas the M2 receptors are located in smooth muscle cells and 
cardiac muscle. M3 receptors are located in exocrine gland, bladder and smooth 
muscles. M1, M3 and M5 function by activating Gq leading to activation of 
phospholipase C. Hydrolysis of phosphatidylinositol-(4,5)-bisphosphate by 
phospholipase C leads to production of diacylglycerol and inositol-(1,4,5)-
trisphosphate which are second messengers that increase the intracellular Ca2+ 
levels. On the other hand, M2 and M4 receptors are coupled to inhibitory Gi 
protein that will inhibit adenylyl cyclase 2 and increase K+ conductance and 
inhibit cyclic adenosine monophosphate cAMP (Figure 1.10). Both of these 
mechanisms of action will ultimately lead to a physiological response by the 
effector organ (Clark, 2012; Eglen, Choppin, & Watson, 2001; Gotti & Clementi, 
2004; Mufson et al., 2009; Paterson & Nordberg, 2000; Westfall, 2009). 
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Figure 1.10: Muscarinic receptors and their signal transduction (taken from Eglen et 
al., 2001). 
1.7.2 Nicotinic receptors 
 The nAChR is an ionotropic pentameric protein belonging to the Cys-loop 
superfamily of ion channel complexes. Other members of the Cys-loop family 
include the GABAA, 5-HT3 and glycine receptors. A number of nAChR genes have 
been identified that encode a total of 17 subunits (α1-10, β1-4, γ, δ and ε). Each gene 
encodes a protein structure of a large N-terminal extracellular domain, an 
extracellular C-terminus domain, four α-helixes (M1-M4) and intracellular loop 
between M3 and M4 (Figure 1.11). The Acetylcholine binds to a site near the α-helix 
where two cysteine tandem residues are located. The “orthosteric” binding site for 
ligands is formed by at least three different peptides the α-helix and three different 
adjacent subunits (complimentary components). The receptor also contains a binding 
site for several compounds with diverse structure that is different from Acetylcholine 
and referred to as the allosteric binding site. Both positive and negative allosteric 
modulators have a separate binding site on the receptor. Nicotinic receptors assemble 
in different combination for example α (2-6) and β (2-4) subunits which influence 
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the receptors pharmacology and biophysical properties. The β3 and α5 subunits fail 
to produce function when alone or paired; however, they can produce function when 
they are expressed as an extra subunit with α and β subunit pairs e.g. α4αβ2β3, 
α5α6β2. The α7, α8, and α9 subunits can form homo-oligomers and hetero-oligomers 
by adding another subunit such as: α7β2 and α9α10 (Figure 1.11) (S. P. H. Alexander 
et al., 2013; Ashoor et al., 2011; Baginskas, Kuraitė, & Kuras, 2015; Davis & de 
Fiebre, 2006; Hendrickson et al., 2013; Wu et al., 2014; Zwart, Strotton, Ching, 
Astles, & Sher, 2014). 
 
 
 Figure 1.11: Structure of Nicotinic acetylcholine receptors and nomenclature taken 
from: (Hendrickson et al., 2013) 
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1.8 Neuronal nicotinic receptors 
 The term “neuronal” implies that these receptors are located in the central nervous 
system but not on the peripheral nervous system. The most common receptors which 
have been identified to be neuronal in nature are the α7 and α4β2 nicotinic 
acetylcholine receptors. They are pentameric in structure which suggests they are 
composed of five subunits. The α7 have been associated with cognitive functions 
and psychosis, while the α4β2 have been linked with analgesia, tobacco addiction, 
learning and memory, although not exclusively. The α7 nicotinic receptor is 
“homomeric” which means it is composed of five α7 subunits while the α4β2 is 
“heteromeric” and is composed of various ratios of α4 and β2 subunits shown in 
(Figure 1.11). The α7 receptor allows entry of Ca2+ while the α4β2 allows the entry 
of both Ca2+ and Na+. Mutations of these receptors would result in various forms of 
disease such as epilepsy associated with α4β2 neuronal receptor and schizophrenia 
associated with α7 mutations (Grady et al., 2010). Up-regulation of the α4β2 
receptors that have high affinity to nicotine in smokers was reported after chronic 
exposure to nicotine both in- vitro and in-vivo (Gotti et al., 2007). The α4β2 was also 
found to be selectively reduced in the cortex of patients with Alzheimer’s disease 
(Gotti et al., 2009).  
 Other Neuronal subtypes have also been identified, for instance, Fowler at al. 
(2011) reported that α5 nAChR in the (Hb-IPN) habenulo-interpeduncular pathway 
subunit plays an important role in nicotinic dependence in rodents by regulating 
nicotine intake and self-administration, this was demonstrated by α5 knockout mice. 
α3β2 which is involved in the visual pathway mainly in the retina and its target 
tissues the Superior Collicolus (SC) and Lateral Ganiculate Nucleus (LGN). On the 
other hand, the α3β4 subtype has been found to be expressed in the pineal gland, 
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cerebellum, retina and involved in the release of noradrenaline in the hippocampus 
(Gotti et al., 2007). Finally, the α4β4 receptor subtype is expressed in both rat and 
chick retinas (Baginskas et al., 2015; Briggs & Gopalakrishnan, 2007; Clementi et 
al., 2000; Davis & de Fiebre, 2006; Fowler, Lu, Johnson, Marks, & Kenny, 2011; 
Gotti et al., 2009; Gotti et al., 1997; Gotti et al., 2007; Grady et al., 2010; Mufson et 
al., 2009; Westfall, 2009) 
This project will focus on the α7 receptor subtype while testing the effect of Thujone 
on the other α4β2, α3β2, α3β4 and α4β4 nicotinic receptor subtypes (Figure 1.12). 
                 
Figure 1.12: Neuronal nicotinic acetylcholine receptors taken from: (Davis & de 
Fiebre, 2006). 
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Chapter 2: Aims and Objectives 
  Our laboratory was interested on the effects of different monoterpenes and their 
role on nAChRs. Earlier studies revealed the effect of the monoterpene Thujone on 
different types of LGICs such as 5-HT3, and GABAA receptors. Since the effects of 
Thujone on the function of neuronal nicotinic nAChR is unknown; our main aim was 
to investigate the effects of Thujone’s on human neuronal nAChR expressed in 
Xenopus oocyte systems. The expression system has the following advantages: 
A. Xenopus oocyte expression systems have been widely employed and well 
described in many previous studies. 
B. We can obtain large number of oocytes with the expression levels necessary to 
conduct the experiment. 
C. Using the two-electrode voltage clamp method along with the Xenopus oocytes 
allows for sensitive yet reliable results and conclusions. 
D. The Two-electrode voltage clamp allows for long periods of recording which 
is important in long-lasting experiments when using oocyte systems.  
The detailed objectives of the experiments are as follows: 
A. To investigate the function of Thujone on different neuronal nAChRs 
expressed in oocytes using the two-electrode voltage clamp. 
B. To investigate the role of intracellular Ca2+ on the effects of Thujone on 
neuronal α7 nAChR expressed oocytes. 
C. To determine the voltage dependence of Thujone on the α7 nAChR expressed 
oocytes. 
D. To investigate the binding site of the Thujone on the nAChR. 
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Chapter 3: Materials and Methods 
3.1  Materials 
3.1.1 Chemicals 
All the chemicals (Table 3.1) used in the experiment were purchased from 
pharmaceutical companies and they were in research grade purity.  
Table 3.1: Chemicals  
Compounds 
Molecular 
weight 
Manufacturer 
Catalogue 
number 
Acetylcholine chloride 181.7 Sigma, USA A6625 
BAPTA 764.68 Sigma Aldrich A-1076 
Barium chloride 244.28 BDH, England R:20-25 S:45 
Benzocaine 165.2 Sigma, USA E-1501 
Calcium chloride 
anhydrous (CaCl2) 
110.99 
Panreac Quimica, 
SA 
Lot. 
#73917PCP 
Collagenase – A (from 
Clostridium histolyticum 
EC.3.4.24.3 
--------- 
Roche Diagnostic 
Corporations, USA 
Lot. 
#93211521 
Gentamicin reagent 
solution 
Conc. 
50mg/ml 
Introgen 
Corporation, China 
Cat. Number 
15750-060 
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HEPES 238.3 Sigma, USA H3375 
Hydrogen chloride (HCL) 37% Sigma Aldrich, USA 25.814.B 
Magnesium chloride 
(MgCl2) 
95.22 Sigma, USA M4880 
Magnesium Sulfate 
(MgSO4) 
246.5 Sigma, USA M9391 
Penicillin G 356.4 Sigma, USA P3032 
Potassium chloride (KCL) 74.55 Sigma, USA P9541 
Sodium Chloride (NaCl) 58.4 Sigma, USA S-3014 
Sodium Bicarbonate 
(NaHCO3) 
84.01 Sigma, USA S6014 
Sodium Hydroxide 
(NaOH) 
40 Amresco, USA 
Lot. 
#214613010 
Sodium Pyruvate 110.04 Sigma Aldrich, USA P2256 
Streptomycin 1457.4 Sigma, USA S9137 
α-Bungarotoxins ~8500 Sigma T-0195 
α-Thujone 152.23 Sigma Aldrich 546-80-5 
α,β Thujone 152.23 Sigma Aldrich 76231-76-0 
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3.2  Female Xenopus laevis frogs 
 Electrophysiological recordings from Xenopus laevis frog oocytes have been 
commonly used for the investigation of ion channels. Importantly, it was demonstrated 
that oocytes have few endogenous channels and they can express foreign proteins 
when injected with their respective RNAs (Eaton et al., 2004; Miledi, Parker, & 
Sumikawa, 1983; Oz, Spivak, & Lupica, 2004; R. L. Papke & Smith-Maxwell, 2009; 
Weber, 1999; Zwart et al., 2014).  
 Mature African wild type female clawed Xenopus laevis frogs (Figure 3.1) were 
obtained from Xenopus Express, Haute-Loire, France and held in reserve in a de-
chlorinated tap water aquarium (dimensions: 100 cm height, 130 cm length, 66 cm 
width) where the water was changed twice per week. The aquarium was placed in an 
ambient room temperature of 18 οC and a 12 hour alternating dark and light cycle. The 
frogs were fed twice a week with special frog’s food pellets that were also supplied 
from Xenopus Express, France. Animal handling and care for all the animals and frogs 
were in accordance with institutional guidelines and approved by the animal Ethics 
Committee of the College of Medicine and Health Sciences (CMHS) of the United 
Arab Emirates University (UAEU).  
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 Figure 3.1: African clawed female Xenopus laevis frog (taken from: xenopus.com) 
3.2.1  Experimental configuration 
 Two-electrode voltage clamp (TEVC) method was used in the study. This 
electrophysiological method clamps the membrane potential by a feedback amplifier 
to allow measurement of the current passing through the membrane at clamped 
potential. Using this method, the pharmacological properties of membrane proteins 
such as ion channels can be investigated. The solutions and drugs were applied by 
gravity flow perfusion tubes that were connected directly to the perfusion chamber 
where the oocyte was placed as shown in (Figure 3.2).  
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Figure 3.2: Two-electrode voltage clamp system 
Table 3.2: Components of the Two-electrode voltage clamp system 
Device Name Company of purchase 
GeneClamp500B 
amplifier 
Axon Instruments, Molecular Devices, Inc, Sunnyvale, 
CA, USA 
Current Head stages 
HS-2A Head stage, Gain 10 MG 
Voltage Head stages 
HS-2A Head stage, Gain 1 MG, Axon instruments, 
Molecular devices, Inc, Sunnyvale, CA, USA 
Magnetic Holding 
device 
Kanetec USA corporation, Bensenville IL, USA 
Manual 
micromanipulator 
M33, Märzhäuser, Wetzlar, Germany 
30 
 
The two electrode voltage clamp consists of the following items: 
 The Computer hardware for data acquisition (Compaq personal computer, Compaq 
Corporation, Wynyard, UK) and analog-digital converter BNC 2081 (National 
Instruments, Austin Texas, USA). 
 Recording chamber illumination used in the recording chamber was supplied by 
an optic fiber light source (Figure 3.2) (Fiber life, Hight intensity illuminator series 
180, Dolan, Jenner Industries Inc., MA, USA)  
 A low-power stereo-dissection microscope was employed for visual observation 
of the recording chamber (Olympus, Tokyo, Japan, SZ-STB1m 100 AL0.5 Xm 
WD186).  
 The perfusion apparatus consisted of perfusion tubes and bottles containing 
extracellular solutions connected to the recording bath by silicon tubing (Cole Parmer 
Instrument Company, O.D. 1/8 inch, WALL 1/32 inch and I.D. 1/16 inch, Vernon 
Hills, Illonois, USA). The flow rate of perfusion was set to 3 – 5 ml/minute. 
 Another multichannel perfusion was used for drug applications that consisted of 
C-flex tubing (Cole Parmer Instruments Company, O.D. 3/32 inch, WALL 1/32 inch 
and I.D.1/32 inch, Vernon Hills, Illinois, USA), 50 ml glass syringes, plastic valves 
and coupling devices. The drug application system was based on gravity flow usually 
through a micropipette that sits directly 2-3 mm from the perfusion chamber where 
the oocyte was placed. On the other end of the recording chamber, a glass suction 
tubing was connected directly to the waste disposal flask that was observed and 
cleaned routinely (Figure 3.3). 
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Figure 3.3: Oocyte perfusion chamber schematic diagram  
3.2.2  Other material used 
Table 3.3: Other devices and materials 
Device or Material Specifications Company of Purchase 
Automatic Nano-liter 
injector 
Nanoject 
Drummond Scientific 
Company, Broomall, PA, 
USA 
Borosilicate Glass tubing 
for microelectrodes 
Glass thin-wlled 
w/filament 1.5 mm, 
Catalog #TW150F-4 
World Precision 
Instruments, Sarasota, FL, 
USA 
Electrode Holder --- 
World Precision 
Instruments, Sarasota, FL, 
USA 
Magnetic stand and 
manipulators 
Catalog #7739 Narishige, Tokyo, Japan 
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Microfill filling syringe --- 
World Precision 
Instruments, Sarasota, FL, 
USA 
Micro-4 Microsyringe 
pump controller 
Model UMC4-C 
World Precision 
Instruments, Sarasota, FL, 
USA 
Petri Dishes Catalog #127,60mm 
Sterillin, Newport, UK 
pH Meter Model 450 
Corning pH meter, 
Albany, NY, USA 
Picofuge Catalog #400550 
Stratagene, Santa Clara, 
CA, USA 
RNAase free water in 1.8 
ml Eppendorf tubes 
Lot #M25/80502 
Epicenter 
Biotechnologies Madison, 
Wisconsin, USA 
Silver Wires --- 
World Precision 
Instruments, Sarasota, FL, 
USA 
Surgical Accessories Scissors, forceps, scalpels 
World Precision 
Instruments, Sarasota, FL, 
USA 
Surgical Sutures 
Catgut chrom, reverse 
cutting 3/8 circle, USP 
4/0, SMI 
SMI, DemeTech 
Corporation, Miami, 
Florida, USA 
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Stirrer 
Rotomix type 50800, 
Model #M50825 
Barnstead/thermolyne, 
Dubuque, IA, USA 
Vertical Puller 
Model 700D, heater 
adjusted to 48 and 
solenoid adjusted to 70 οC 
to get resistance of 1-2 
MΩ 
David Kopf Instruments, 
Tujunga, CA, USA 
3.3 Methods 
3.3.1 Preparation of Modified Barth’s Solution (MBS) 
The Modified Barth’s Solution was mainly used during isolation of the oocytes and 
will be discussed in later chapters. The composition of MBS is shown in (Table 3.4) 
A. Calcium free MBS solution: 
Table 3.4: MBS Solution 
Compound 
Concentration 
(mM) 
1x (Weight in 
Grams) 
10x (Weight in 
Grams) 
HEPES 10 2.38 
23.8 
KCl 1 0.075 
0.75 
MgSO4 0.8 0.2 
2 
NaCl 88 5.14 
51.4 
NaHCO3 2.4 0.2 
2 
All the above compounds were dissolved in 1 L of distilled water using a 
magnetic stirrer and plate and the pH was adjusted using NaOH to 7.5. 
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B . MBS with Calcium:  
To prepare this solution, 0.22 g and 2.2 g of CaCl2 was added to the above 
components to make stock solutions of 1x and 10x respectively, and they were 
dissolved in 1 L of distilled water and the pH was adjusted to 7.5 using NaOH.  
3.3.2 Preparation of oocyte storage solution  
 The storage solution was used to keep the oocytes in incubators at 18ο degrees for 
7- 10 days. The composition of the storage solution is shown in (Table 3.5) 
Table 3.5: Oocyte storage solution 
Compounds Concentration (mM) Weight in Grams 
CaCl2  2 
0.22 
Gentamycin 50 mg/L 
2 mL 
HEPES 10 
2.38 
KCl  1 
0.075 
MgSO4 0.8 
0.2 
NaCl 88 
5.14 
NaHCO3 2.4 
0.2 
Penicillin G 100000 U/L 
0.019 
Sodium Pyruvate 2 
0.22 
Streptomycin 10 mg/L 
0.01 
Theophylline 0.5 
0.09 
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3.3.3 Preparation of Frogs Ringer Solution  
 The Frogs Ringer solution (ND96) is the working extracellular solution that 
was used in the two-electrode voltage clamp system to record the nAChR 
mediated ion currents. The composition of the (ND96) is shown in Table 3.6. 
Working solutions of 1x were adjusted to pH 7.5 using NaOH before the 
experiment. 
Table 3.6: Frogs Ringer Solution (ND96) 
Compounds 
Concentration 
(mM) 
1x (Weight in 
Grams) 
10x (Weight in 
Grams) 
CaCl2 1.8 0.2 
2.0 
BaCl2 Or CaCl2  1.8 0.439 
4.39 
HEPES 5 1.19 
11.9 
KCl 2 0.15 
15 
MgCl2 1 0.10 
1.0 
NaCl 96 5.61 
56.1 
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3.3.4 Isolation of Oocytes from Xenopus Laevis 
 Once a week, surgery was performed on a frog for oocyte collection. After a 2-3 
month recovery period the same frog was used again. Each frog could be used for 4 
oocyte collection procedures. The frog was brought in 1 L of cold tap water from the 
animal house aquarium where all the frogs are located and securely stored. The frog 
was anesthetized by immersion in 0.03% w/v p-aminobenzocaine prepared by 
dissolving 300 mg of ethyl p-aminobenzocaine in 15 mL of 70% ethanol which were 
immersed in the 1 L of cold tap water which contains the frog. The frog was then 
monitored for the unset of anesthesia by pinching of the lower limbs and usually takes 
about 5 minutes for the animal to be completely anesthetized. Afterwards, the frog 
was placed on a bed of ice to keep its body temperature low during the surgery.  
 To perform the surgery, all the surgical instruments were sterilized using 70 % 
ethanol. A 1.5 cm incision was made using a surgical scalpel through the epidermis 
vertically around the right, middle or left of the lower abdominal area. Another deeper 
incision was made to the muscle layer where the oocyte lobes are located using 
surgical scalpel and scissors. A single lobe or pair of lobes of ovaries containing 
oocytes were removed (Figure 3.4) and placed on a petri dish containing Calcium 
Free MBS solution. Subsequently, the muscle layer of the abdomen and epidermal 
layer were sutured using absorbable Catgut sutures. The frog was then placed in a 
container of water and monitored during recovery. All the procedures conducted in 
these experiments were approved by the Animal Ethics Committee of College of 
Medicine and Health Sciences (CMHS), United Arab Emirates University (UAEU).   
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Figure 3.4: Two oocyte containing ovaries in different stages of development taken 
from: (http://ibmmsrvlakitu.unibe.ch/sigel/xenopicts.html 
3.3.5 Oocyte preparation 
 After extraction of the oocyte lobes from the frog, the epithelial and follicular layers 
on the oocyte surface were removed by treatment with collagenase solution at room 
temperature. The collagenase was prepared by dissolving 50 mg of Collagenase, type 
A (from Clostridium histolyticum, Roche Diagnostic Corporations, USA) in 25 mL 
of Calcium Free MBS solution and transferred in two separate small conical flasks. 
The oocytes were placed in two 12.5 mL Collagenase containing flasks for two hours 
stirring slowly at 60-80 rotations/minute. At the end of the 1st hour, collagenase 
solution was replaced with fresh collagenase solution for the 2nd hour. Subsequently, 
the oocytes were washed 6 times using Calcium Free MBS and another 6 times with 
Calcium containing MBS solution. Then the oocytes were placed in a Calcium MBS 
containing petri dish for oocyte separation and selection. In the selection step, the 
oocytes are selected under a dissecting microscope (Bunton Instruments Co Inc, 
Model GSZ, Rockville, MD, USA). All the selected oocytes were stage V and VI 
which were larger in size with round shape, 1.0 mm - 1.2 mm diameter and clearly 
separated dark brown and yellow vegetal animal poles as shown in (Figure 3.5). 
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Figure 3.5: Individual oocyte isolated from Xenopus laevis frog after treatment with 
collagenase taken from: (http://ibmmsrvlakitu.unibe.ch/sigel/xenopicts.html) 
3.3.6 Ion channels endogenously expressed in the oocytes 
  The Xenopus oocytes can express a wide number of receptors, ion channels 
and transporter proteins. Nevertheless, oocytes also contain various endogenously 
expressed transporter proteins, ion channels that could interfere with the expression 
level and the functional properties of exogenously expressed channels or proteins, 
the first type is voltage-gated ion channels (VGIC) which can further include: 1) 
Voltage-Gated Ca2+ channels, 2) Inducible Na+ channels, 3) Transient Na+ channels,  
4) Amiloride-sensetive N+ channels, 5) Rapidly inactivating K+ channels, 6) Delayed 
rectifier ISDN-sensitive K+ channels and 7) Hyper-polarization-activated Cl- 
channels. The second type of endogenously expressed receptors are Ligand-activated 
ion channels (LGIC) which include: 1) Ca2+ activated Cl- channels, 2) Na+ channels, 
3) K+ channels, 4) Store-operated Ca2+ channels (SOC) and 5) iGluRs containing 
endogenous. (Terhag, Cavara, & Hollmann, 2010(Roger L. Papke, Boulter, Patrick, 
& Heinemann, 1989; Sands, Costa, & Patrick, 1993; Weber, 1999). Our experiments 
were designed to eliminate the contribution of Ca2+ activated Cl- channels mediated 
inward currents which will be discussed in later chapters.  
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3.3.7 Advantages and disadvantages of oocyte expression system 
3.3.7.1 Advantages 
 Large number of oocytes can be isolated from each frog. 
 The cells are large in size and can be easily injected with cRNA. 
 The cells can remain alive for periods up to 2 weeks. 
3.3.7.2 Disadvantages 
 The small number of endogenous expressed proteins can interfere with the 
actual current measurements. 
 The oocytes can deteriorate when exposed to high temperatures so the 
recording must be performed at temperatures of 18-23 οC. 
 Expressed channels can function differently from native cells due to 
posttranslational modifications.  
3.4 Synthesis of cRNA 
 The Capped cRNA transcripts were synthesized using mMASSAGE mMACHINE 
kit in-vitro (Ambion, Austin, TX, USA) and analyzed by using 1.2% formaldehyde 
agarose gel to check the quality and size of the transcripts. This procedure for cDNA 
cloning of human nAChRs was provided by Dr. J. Lindstorm (University of 
Pennsylvania, PAM, USA). The final concentration synthesized for the human 
nAChRs mRNA was 3.7 µg/µL. 
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3.4.1 Microinjection of cRNA 
 The human nAChRs mRNA was kept in 1 µl aliquots in a -80 οC freezer and stored 
there for microinjection. After oocyte preparation one aliquot of RNA was transferred 
to the laboratory on an ice bucket. The bench was sterilized using 70 % ethanol and 
masks and gloves were worn during microinjection to minimize RNAase 
contamination. Using a micro-centrifuge the tube was centrifuged at 1200 rpm for 1-
3 minutes and 8 µL of RNAase and DNAase free water was added to the 1 µl cRNA 
pellet by the use of a sterile pipette and RNAase DNAase free pipette tips (Denville 
Scientific Inc., Metuchen, NJ, USA). During the microinjection only 3-4 µL of diluted 
cRNA was required for each batch of oocytes and the remaining cRNA was returned 
to the freezer for storage. Microelectrodes used for micro-injection were prepared 
with a horizontal puller PIL-1 (World Precision Instruments, Sarasota, FL, USA) 
using autoclaved glass capillaries (World Precision Instruments, Sarasota, FL, USA). 
The fine needle shaped tips of the glass microelectrodes were broken by applying a 
gentle pressure using a fine pair of forceps (Fine Science Tools Inc., Vancouver, 
Canada) under a dissecting microscope (Bunton Instruments Co., Rockville, MD, 
USA).  
 Subsequently, the electrode needle was back filled with mineral oil (Sigma, St. 
Louis, MO, USA) using a 1 mL glass syringe. The electrode needle was fixed in the 
micro-dispenser which was controlled by the micromanipulator. The next step was to 
withdraw the 3 µL of diluted cRNA or distilled water drop by the micro-injector and 
the mineral oil filled glass. Using the withdrawal knob of the micro-dispenser 
controller the mRNA containing aqueous phase was drawn into the needle. This step 
was performed under the dissecting microscope to make sure that the tip of the needle 
was always at the center of the droplet while drawing the solution (Figure 3.6).  
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Figure 3.6: Micro injector (Nano-injector) and dissecting microscope. The oocyte 
micro injector unit consisted of a micro injector mounted in the micro-manipulator. 
A control box to adjust the amount of solution and a low power dissecting 
microscope.  
 The selected oocytes were placed in a U shaped arrangement in a round mesh-
bottom petri dish that provided mechanical support to the oocytes during the injection. 
The oocytes were impaled by the microelectrode needle and 25-30 nL mRNA or 
distilled water were injected into each oocyte using the nano-liter injector (micro-
injector) guided by a Micro-4 micro syringe pump controller. Each petri dish filled 
with injected oocytes was then labeled and stored in oocyte storage solution at 18 οC 
in a fridge. The oocytes were divided into two groups, the first group contained cells 
injected with cRNA encoding human nAChRs and the second group of was the 
control which was injected with distilled water. The groups were stored in 18 οC fridge 
for 48-72 hours prior to two-electrode clamp experiments to achieve maximal 
expression of receptors. The injected oocytes were used for experiments for 7 - 10 
Micro injector Control box 
Low power stereo 
microscope 
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days during which the storage solution was replaced on a daily basis and the cells 
with poor quality were removed under the dissecting microscope and were not used 
in experiments.  
3.4.2 Drug preparation 
 Stock solutions of the test compounds were all prepared in ND96 solution using 
the following formula: 
Weight (mg) = (MW) x (Volume (L)) x (concentration (mM)) 
Further dilutions were also prepared using the Charles equation: 
C1 x V1 = C2 x V2 
C1 = concentration of stock solution 
V1 = volume of stock solution 
C2 = concentration of the solution to be prepared 
V2 = volume of C2 of the solution to be prepared  
Required dilutions and fresh stock solutions were all prepared fresh before the start 
of experiments. 
3.5 Electrophysiological recording 
 The two-electrode voltage clamp technique is a widely used method. It measures 
the electric current generated by the flow of ions across the cell membrane while 
clamping the trans-membrane potential at a specific value (in our experiments usually 
-70 mV). This is done by using a feedback amplifier. This technique allows the 
evaluation of the functional properties of different proteins expressed in Xenopus 
oocytes. The membrane potential (measured by the voltage sensing electrode and high 
input resistance amplifier) is compared with a command voltage and the difference is 
brought to zero by a feedback amplifier. The second electrode measures the total 
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current generated by the amplifier to keep the oocyte at the clamped potential (Figure 
3.7). 
 
Figure 3.7: Illustration of electrical circuitry connecting oocytes to the recording set-
up (Schematic Diagram)  
 The oocytes were transferred to the perfusion chamber and bathed in ND96 solution 
at a perfusion rate of 5-7 mL/minute (Figure 3.2). Prior to each experiment, two glass 
microelectrodes were prepared by a vertical puller (David Kopf Instruments Tujunga, 
CA, USA) and the animal pole (the dark side) was impaled by the two glass 
microelectrodes filled with 3M KCL solution with a resistance of 1-2 MΩ. Drugs 
were applied by a micropipette placed about 2 mm away from the oocytes, and 
operated by gravity flow based multichannel application system. Two-electrode 
voltage clamp was performed using a Geneclamp 500 amplifier (Axon Instruments, 
Molecular Devices, Inc, Sunnyvale, CA, USA) that was interfaced to a PC computer 
equipped with data acquisition software (Win WCP, University of Strathclyde, 
Glasgow, UK). 
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3.6 Tested electrophysiological parameters 
αβ and α Thujone purchased from Sigma Aldrich were dissolved in absolute 
Ethanol to prepare a 100 mM stock solution. Further final dilutions were prepared 
using distilled water. Working dilutions of drug perfusion and ND96 must not 
contain Ethanol concentrations of more than 0.3% (v/v) for the nAChRs because 
our published results indicate that concentrations of Ethanol higher than 0.3% 
interferes with the function of nicotinic receptors. 
3.6.1 Concentration response curves 
 Acetylcholine (ACh) was selected as it is the endogenous agonist of nicotinic 
receptors. Furthermore, ACh has less desensitizing properties on nAChRs compared 
with other agents like nicotine.    
 Control readings of ACh induced currents (3-5 recording) at 5 min intervals were 
obtained followed by wash out with regular ND96 solutions. The average of 3 or 4 
readings were calculated and recorded as the control. Subsequently, the oocytes were 
perfused for a total of 15 minutes with the selected concentrations of Thujone. The 
average of two to three responses at the end of the 15 min drug application were 
calculated to determine the effect of Thujone co-application with ACh. Finally, drug 
perfusion was stopped and ND96 perfusion was restarted to record the recoveries of 
ACh induced currents.  
 By comparing the maximum current amplitudes in the absence and presence of 
Thujone, the percent inhibition of the drug was calculated. The values were 
normalized and displayed as percent changes compared to controls. Using different 
concentrations of Thujone, it was possible to construct dose response curves. For each 
concentration of Thujone, averages of 5-6 oocytes were used. 
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 The concentration of Thujone that caused a 50 % inhibition of ACh-induced 
currents (IC50) was calculated by nonlinear curve-fitting and regression fits (logistic 
equation) using statistical software (Origin, OriginLab Corp., Northampton, MA, 
USA).  
3.6.2 Competitive and non-competitive inhibition  
 In this experiment, different concentrations of ACh, ranging from 1 µM to 1mM, 
were used in the absence and presence of a fixed concentration of α-Thujone. Cells 
were clamped at a holding potential of -70 mV using the GeneClamp500. An average 
of 5-6 oocytes were used for each concentration and the percent inhibition was 
recorded and calculated. Concentration response curves were plotted using computer 
software (Origin, OriginLab Corp., Northampton, MA, USA).  
3.6.3 Voltage dependency of drug inhibition 
 In these experiments, the membrane potential was held at different values ranging 
from +20 mV to -120 mV for 30 seconds just before current recording to observe the 
effect of drug at different membrane potentials. After each recording the potential was 
returned back to -70 mV and the recordings were performed at 5 min intervals. The 
ACh concentration was fixed at 100 µM at all tested holding potentials. The 
relationship between voltage and current (I-V relationship) for the ACh induced 
currents were determined in the absence and presence of α-Thujone. 
3.6.4 Effect of Ca2+ on drug action  
 These experiments were conducted to determine the role of intracellular Ca2+ on α-
Thujone inhibition of ACh induced currents. 50 nL of 100 mM stock solution of 
BAPTA (1,2-bis (o-aminophenoxy) ethane-N, N, N’, N’-tetraacetic acid) was 
injected into each oocyte just before the electrophysiological recording (Sands, Costa 
and Patrick 1993b). Subsequently, the oocytes were kept in ND96 for 5-10 min and 
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then transferred to ND96 solution containing 2 mM Ba2+ instead of Ca2+. The stock 
solutions of BAPTA were prepared in distilled water and the pH was adjusted by 
CsOH to 7.4 pH. The ND96 contained 1.8 mM BaCl2 instead of 1.8 mM CaCl2. 
3.7 Statistical data analysis 
 Origin version 8.1 (Origin Lab Corp., Northampton, MA, USA) was used for 
nonlinear curve fitting. The average values were calculated as the mean ± standard 
error means (SEM). ANOVA or Student’s t-test was used for statistical analysis. 
Specific p value of p≤0.05 was considered significant. Concentration response curves 
were acquired by fitting the data to the logistic equation: 
y = Emax / (1+ [x / EC50] n) 
Emax = maximal response (Keverne & Ray, 2005) 
x = drug concentration 
y = response  
EC50 = half the maximal concentration 
n = slope factor (apparent Hill coefficient) 
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Chapter 4: Results 
4.1 Effects of ACh and α-bungarotoxin on α7 nAChRs 
 The endogenous nAChR agonist ACh was used to activate the nicotinic 
receptors. In oocytes injected with cRNA of human α7 nAChRs, the application of 
100 µM of ACh for 3-4 seconds caused fast inward currents (Figure 4A, control 
currents) indicating that ACh induced currents were mediated by a protein 
synthesized by the injection of human α7 nAChRs. In line with these findings, the 
bath application of ACh for 4 seconds did not elicit a response on the oocytes 
injected with distilled water (Figure 4B).  
 In the same experiment, α-bungarotoxin which is a selective and potent 
inhibitor of the α7 nAChRs obtained from snake venom was used to verify the 
pharmacology of these receptors. ACh-induced currents were significantly 
inhibited by 30 nM α-bungarotoxin (Figure 4A, 4B). The recoveries were slow and 
incomplete during the washout period (Figure 4A, right panel). 
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Figure 4.1: Control experiments demonstrating the functional characterization of 
ACh induced currents. (Figure 4.1.A) Current traces of control 100 µM ACh (left 
panel), after 10 minutes bath application of 30 nM α-bungaratoxin (middle panel) 
and following 15 minute washout 100 µM ACh (right panel). Bars represent the 
means of maximal amplitudes of effects of ACh-induced currents vs distilled water 
injected oocytes and human α7 nAChR 50 ng cRNA injected oocytes are shown in 
(Figure 4.1.B). The numbers of oocytes tested were represented for each group on 
top of each bar (n) in (Figure 4.1.B). In oocytes injected with human α7 nAChR 
cRNA, the mean maximal amplitudes of ACh-induced currents in the presence and 
absence of α-bungaratoxin were presented on the right side of the (Figure 4.1.B) 
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4.2 Time and Concentration effects of α-Thujone on α7 nAChR 
 The following experiments (Figure 4.2) involves the time and concentration effects 
of α-Thujone on the α7 nAChR induced currents.  
 In the Figure 4.2.A the current traces show the effects of 100 µM ACh in control 
conditions (left panel), followed by 10 minutes bath application of α-Thujone (100 
µM) co-applied with Acetylcholine (100 µM) and finally the recovery after 15 min α-
Thujone wash out (right panel). 
 Figure 4.2.B shows the time course of the effect and the recovery of α-Thujone 
application, on the maximal amplitudes of currents induced by the application of 100 
µM ACh for 15 min. Time course of the effect of vehicle (0.1% Ethanol; filled circles) 
and α-Thujone (100 µM; open circles) on the maximal amplitudes of ACh induced 
currents. Each data point represents the normalized mean ± S.E.M. of 6 - 8 
experiments.   
 We have also investigated the time course of α-Thujone inhibition by comparing 
various pre-incubation times of α-Thujone on ACh induced currents Figure 4.2.C. 
The ACh induced currents in the presence of α-Thujone (co-application) without pre-
incubation did not cause a significant change in the amplitudes of currents (as seen 
before break sign on the X-axis) and the small augmentation of currents was not 
statistically significant (P > 0.05 paired t-test. 6–7 oocytes). However, pre-incubation 
of α-Thujone 100 µM before the (ACh + α-Thujone) co-application caused a 
significant inhibition of the α7 nAChR mediated induced ion currents. The mean 
inhibition as a function of α-Thujone pre-incubation times was presented in the figure 
after the break sign on the X-axis and ultimately, the half maximal inhibition or (τ1/2) 
was calculated to be 1.4  ± 1 min (n= 6-7 oocytes). Usually in our experiments and 
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the majority of the time we pre-incubated with α-Thujone before co-application for 
10 - 15 min to ensure equilibrium conditions.  
 Figure 4.2.D. demonstrates the concentration-response curve for α-Thujone. 
Increasing the concentrations of α-Thujone caused further decrease in the amplitudes 
of 100 µM ACh-induced currents and shows that α-Thujone inhibited the α7 nAChR 
function in a concentration dependent manner with an IC50 of 24.7 µM.  
                           
 
 
Figure 4.2: Effects of α-Thujone on α7 nAChR: (A) Records of currents activated 
by 100 µM ACh in control conditions (left panel), after 10 min pre-treatment with 
100 µM α-Thujone co-application (middle panel), and 15 min washout (right 
panel). (B) Time-course of the effect of vehicle (0.1% Ethanol; filled circles) and α-
Thujone (100 µM open circles) on the maximal amplitudes of ACh induced 
currents. Each data point represents the normalized mean ± S.E.M. of 6 – 8 
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experiments. The horizontal bar represents the application duration of both the 
Vehicle and α-Thujone. (C) The effect of pre-application of α-Thujone. Increased 
pre-application time significantly increased the inhibition of α7-nACh receptors. 
Each data point represents the mean ± S.E.M. of 6 – 7 oocytes. (D) The 
concentration dependence time course of α-Thujone inhibition. Each data point 
represents the mean ± S.E.M. of 6 – 9 oocytes. The curve is best fit of the data to 
the logistic equation described in the methods section.  
4.3 Effects of α-Thujone on endogenous Ca2+ dependent Cl- Channels and 
voltage dependence 
 In order to understand the mechanisms involved in α-Thujone’s inhibition, 
further investigations were conducted on α7-nAChRs. It has been shown in previous 
studies that the α7-nAChRs have a high permeability for Ca2+ cations. Entrance of 
Ca2+ through α7-nAChRs has been shown to activate endogenous Ca2+ dependent Cl- 
channels (Sands et al., 1993; Seguela, Wadiche, Dineleymiller, Dani, & Patrick, 
1993). In order to find whether α-Thujone acts on endogenous Ca2+ dependent Cl- 
channels, we have recorded nAChR induced currents in Ca2+ free solution by 
replacing Ca2+  in the extracellular solution with Ba2+ since Ba2+  can pass through the 
receptors without activating these endogenous Ca2+ dependent Cl- channels (Sands et 
al., 1993). 
 It has also been proposed by (Sands et al., 1993) that even when Ba2+ is present, 
endogenous Ca2+ dependent Cl- channels are not completely eliminated. Therefore, 
we have blocked the activity of these channels by the intracellular injection of 
BAPTA (1,2-bis (o-aminophenoxy) ethane-N,N,N’,N’-tetraacetic acid) a Ca2+ 
chelating agent. Experiments were performed in BAPTA injected oocytes and 
perfused with an extracellular solution of 2 mM Ba2+ instead of Ca2+ cations (Sands 
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et al., 1993). The bath application of 100 µM α-Thujone caused the same level of 
inhibition (80 ± 5 % in controls versus 78 ± 5 % in BAPTA injected oocytes; 
ANOVA, P >0.05) on ACh induced currents when compared to BAPTA injected 
oocytes recorded in 2 mM Ba2 (Figure 4.3A). 
 It is possible that the inhibition of receptors is altered by changes in membrane 
potential. Therefore, we have investigated if the inhibition of α-Thujone was effected 
by membrane potential. As shown in Figure 4.3B in the presence (circles) and 
absence (filled circles) of 100 µM α-Thujone, ACh induced currents were recorded 
and normalized to controls at different voltages from -120 mV to 0 mV. The 
membrane potential was held at voltages between -120 and 0 mV for 30 seconds 
before each current recording and returned to the holding potential of -70 mV. Figure 
4.3C show the extent of α-Thujone induced inhibition at different voltages. The 
results reveal that the inhibition of α-Thujone 100 µM was not changed by alterations 
in membrane potential (P>0.05, n=6, ANOVA).  
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Figure 4.3: Effects of α-Thujone on endogenous Ca2+ dependent Cl- Channels and 
voltage dependence. In the presence of BAPTA, the effects of α-Thujone on α7-
nAChRs are not dependent on intracellular Ca2+ levels and changes in membrane 
potential. The effects of 100 µM α-Thujone (10 min) on the maximal amplitudes of 
ACh induced currents in oocytes injected with 50 nl distilled water controls (n=5) or 
BAPTA (50 nl, 200 mM, n=6). Bars represent the means ± S.E.M. of 5 – 6 
experiments. (B) Current-voltage relationship of ACh induced currents in the absence 
and presence of α-Thujone. Normalized currents activated by 100 µM ACh before 
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(control, filled circles) and after 10 min treatment with 100 µM α-Thujone (open 
circles). Each data point presents the normalized means ± S.E.M. of 5 – 6 
experiments. (C) Quantitative presentation of the effect of α-Thujone as percent 
inhibition at different voltages. Each data point presents the normalized means ± 
S.E.M. of 5 – 6 experiments. 
4.4 Non-competitive effects of α-Thujone on α7 nAChR 
 Furthermore, we examined the possible sites mediating the effect of α-Thujone on 
the α7-nAChRs. We investigated whether α-Thujone acts as a competitive or non-
competitive antagonist of these receptors. ACh induced concentration response 
curves were plotted in the absence and presence of α-Thujone (Figure 4.4). The 
maximum response induced by ACh was reduced to 30 ± 5% (n= 8-12), whereas the 
EC50 values remained unchanged. (93±8 µM in controls versus 98±7 µM α-Thujone, 
ANOVA, P>0.005, n=5-8). These results provide evidence that α-Thujone inhibits 
the function of α7-nAChRs and ACh-induced currents in a non-competitive manner. 
 
Figure 4.4: Concentration-response curve for α-Thujone during increasing 
concentrations of ACh. Filled circles indicate the ACh induced currents. Open circles 
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indicate the responses in the presence of α-Thujone. Responses are normalized to 
maximal ACh induced currents. Each data point presents the normalized means ± 
S.E.M. of 5 – 6 experiments.  
4.5 Effects of Thujone Sterioisomers on α7 nAChR 
 Since Thujone has two major stereoisomers, we have investigated whether these 
stereoisomers would behave differently on the human α7 nAChRs, so we compared 
the percent of inhibition of both 100 µM α-Thujone and 100 µM αβ-Thujone (Figure 
4.5). The level of inhibition of the current traces was similar for both compounds with 
no statistical significance (ANOVA, P>0.05, n=5-6).  
 
Figure 4.5: Percent of Inhibition of α-Thujone and αβ-Thujone on human α7-nAChRs 
induced currents with 100 µM Acetylcholine. Each data point presents the 
normalized means ± S.E.M. of 5 – 6 experiments.  
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4.6 Effects of Thujone on different nAChRs 
 In the last set of experiments were compared. The effects of α-Thujone on different 
subtypes of the nAChRs were compared. The level of inhibition between different 
subtype combinations of nAChRs indicated that α-Thujone has the highest potency for 
α7 nAChRs. Although α4β2 was also significantly inhibited, the extent of inhibition 
by α-Thujone was significantly less than that of α7 nAChRs (Figure 4.6.)  
 
Figure 4.6: Percent of inhibition of 100 µM α-Thujone co-applied with 100 µM ACh 
on different nAChRs induced oocyte currents. Each data point presents the 
normalized means ± S.E.M. of 5 – 6 experiments.  
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Chapter 5: Discussion 
 The results of our study indicate that Thujone binds non-competitively to α7-nACh 
receptors and causes time and concentration dependent inhibition.  
 In an earlier study the mechanism of Thujone neurotoxicity was investigated (Hold 
et al., 2000). It was demonstrated that the poisoning signs of Thujone (and their 
alleviation by diazepam and phenobarbital) in mice are similar to those of the classical 
antagonist picrotoxin suggesting that GABAA receptors are involved in Thujone 
toxicity. Secondly, a strain of Drosophila specifically resistant to chloride channel 
blockers was found to be tolerant to Thujone. Third it was shown that Thujone is a 
competitive inhibitor of a GABAA receptor ligand, [
3H]ethynylbicycloorthobenzoate 
binding to mouse brain membranes. In addition, peak currents induced by GABA in 
rat dorsal root ganglion neurons are suppressed by Thujone with an IC50 value of 21 
µM (Hold et al., 2000). The action of Thujone on GABAergic miniature inhibitory 
post-synaptic currents (mIPSCs) and on responses to exogenous GABA applications 
was also studied in cultured hippocampal neurons (Szczot et al., 2012). Thujone 
reduced mIPSC frequency and amplitude and also moderately affected their kinetics, 
indicating both pre- and postsynaptic mechanisms. Analysis of current responses to 
exogenous GABA revealed that Thujone reduced their amplitude, affecting their onset, 
desensitization, and deactivation, suggesting an effect on the gating of GABAA 
receptors (Szczot et al., 2012). However, GABAA receptors are highly heterogeneous 
and the effects of Thujone have also been investigated on different recombinant 
GABAA receptors (α1β2γ2L, α1β2, α1β2δd and α4β2δ) relevant to phasic or tonic 
forms of GABAA responses. It was shown that α-Thujone, in the concentration range 
of 100 to 300 µM, inhibits all receptor subtypes by a qualitatively similar mechanism 
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but the strongest effect was observed for α1β2δ receptors, suggesting that tonic 
currents might be more sensitive to Thujone than the phasic ones. Moreover, tonic 
currents, mimicked by response to a sub-µM GABA concentration (0.3 µM) in 
cultured neurons, showed a substantially larger sensitivity to Thujone than responses 
elicited by higher [GABA] (more similar to phasic currents) or inhibitory postsynaptic 
currents in the same preparation. Importantly, the extent of tonic current inhibition by 
α-Thujone was as strong as in the case of currents mediated by α1β2δ receptors. 
Collectively, these data provide evidence that different GABAA receptor subtypes 
show distinct sensitivities to α-Thujone and suggest that this compound may 
differentially affect tonic and phasic components of GABAergic inhibition 
(Czyzewska and Mozrzymas, 2013). 
 Studies on the neurotoxic actions of Thujone have also been extended to fear-anxiety 
behaviors (Rivera et al., 2014). Higher doses of Thujone were convulsant by eliciting 
a toxic and excitatory action. Their results showed that a dose of 78 nmol of Thujone 
had an anxiogenic-like effect observed as an increased latency to ambulate and a 
reduced locomotor activity in open field experiments. Nevertheless, only the central 
administration of Thujone reversed the increase induced by acute stress in the 
flunitrazepam-sensitive GABAA receptor recruitment. These findings demonstrated 
that Thujone, when intracerebroventricularly administered, suppressed the GABAA 
receptor recruitment induced by acute stress, may be due to Thujone blocking the 
benzodiazepine binding site or another site of the GABAA complex (Rivera et al., 
2014).  
 The effects of α-Thujone have also been investigated on 5-HT3 receptors, another 
member of ligand-gated ion channel family. In earlier studies (Deiml et al., 2004), 
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patch-clamp experiments revealed an inhibitory action of Thujone on both homomeric 
(5-HT3A) and heteromeric (5-HT3AB) 5HT3 receptors expressed in HEK-293 cells. 
Their results indicated that in homomeric receptors, α-Thujone enhanced the inherent 
channel-blocking potency of the natural ligand, 5-HT. The IC50 value for α-Thujone 
was found to be 60 µM. On the other hand, in heteromeric receptors, α-Thujone 
recruited an additional channel-blocking component of the agonist. It was suggested 
that α-Thujone reduced 5-HT3 receptor activity by an effect on mechanisms involved 
in receptor desensitization, which depend on receptor subunit composition.  
 Although, the α7 nAChRs are known to cause an increase in the intracellular Ca2+ 
levels and to activate endogenous Ca2+ dependent Cl- channels, our results indicate 
that α-Thujone does not activate these channels indicating that the effects of α-Thujone 
observed in our experiments are not due to its effects on these channels.  
 In addition, α-Thujone was able to bind and inhibit the α7 nAChRs in a non-
competitive manner. Our results show that even high concentrations of ACh cannot 
reverse the inhibitory effect of α-Thujone, indicating that α-Thujone does not compete 
with ACh. α-Thujone is a monoterpene ketone, and these compounds have highly 
volatile and non-polar (lipophilic) structures that usually allow high membrane 
penetration (Clarke, 2008a). Considering the relatively slow onset of α-Thujone action 
(τ=1.4 min), lack of voltage-dependency, and the non-competitive nature of α-Thujone 
inhibition the results suggest that a hydrophobic binding site located in transmembrane 
domains of nAChR is likely to mediate the effects of α-Thujone on nAChRs.  
 Monoterpenes such as Thujone possess variable basic skeletons and exhibit 
stereoisomerism. It has also been shown that some of the biological effects of 
monoterpenes (Clarke, 2008b) and Thujone (Rivera et al., 2014) show stereo specific 
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action in in-vitro studies. However, our results indicate that α-Thujone and the racemic 
αβ-Thujone (β-Thujone is commercially unavailable) caused similar extents of 
inhibition suggesting that the effect of Thujone does not require stereospecific binding 
for its inhibitory actions in-vitro, because in-vivo models could behave differently.  
 Cholinergic nAChRs are involved in the pathogenesis of several diseases such as 
Alzheimer disease (AD), myasthenia gravis (MG), neuro-inflammation, and nicotine 
addiction (Gotti & Clementi, 2004; Keverne & Ray, 2005; Mufson et al., 2009). The 
results of these studies have not been conclusive possibly because more types of 
nAChRs are involved (for a review; Oz et al., 2013). In these studies, both inhibition 
and activation of nAChRs have been linked to pro-cognitive and pro-inflammatory 
effects. Many compounds such as Acetylcholinesterase AChE Inhibitors such as: 
Galantamine, Donepezil and Tacrine also target the same α7 nAChRs with actions of 
both stimulation and inhibition (Keverne & Ray, 2005). Other drugs involved in AD 
such as Memantine have also been reported to cause an inhibition on the α7 nAChRs 
(Eglen et al., 2001; Gangadhar, Mishra, Sriram, & Yogeeswari, 2014; Keverne & Ray, 
2005). 
 Finally, in addition to α7-nAChR, other nicotinic receptors such as: α4β2, α3β2, 
α3β4 and α4β4 have been shown to be expressed in both the central and peripheral 
nervous systems. Therefore, we have investigated the effect of Thujone on these 
receptor subtypes. Our results indicated that, compared to other nAChR tested in our 
study, Thujone acted most potently on α7-nAChR suggesting that the effects of 
Thujone are somewhat specific to α7-nAChR.   
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Chapter 6: Conclusion 
 This study provides the first evidence for the effects of Thujone on different 
nAChRs, such as α7, α4β2 α3β2, α3β4 and α4β4. The study suggests that these 
receptors have pharmacologically different sensitivities to α-Thujone. Although α4β2 
receptors were inhibited by 100 µM α-Thujone, the potency of Thujone on α7-nAChRs 
were significantly higher than α4β2 receptors. Inhibition by α-Thujone was 
concentration dependent with IC50 of 24.7 µM. It appears that α-Thujone acts as a non-
competitive antagonist on the α7 nAChRs. The effect of α-Thujone is not voltage 
dependent and does not involve endogenous Ca2+ dependent Cl- channels. There is no 
significant difference between α-Thujone and αβ-Thujone racemic mixtures regarding 
the extent of its inhibitory effect on nAChR. In conclusion, our results suggest that 
Thujone inhibits nAChRs and could lead to the development of new compounds 
effecting these receptors. 
 6.1  Limitations and Future directions: 
  In this study, we did not examine the effects of Thujone on mammalian cell 
lines and native neurons. It is possible that post-translational modification in Xenopus 
oocytes are different from mammalian cell lines. In future studies we could study the 
effects of Thujone on nicotinic receptors expressed in mammalian cell lines.  
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